Inflammation

Items 2121-2130 of 2823

per page
Set Descending Direction
  1. Lariatin A
    CAS  732286-09-8
    AG-CN2-0120
    AG-CN2-0120-C250250 µg
    CHF 150.00
    AG-CN2-0120-M0011 mg
    CHF 450.00
    Lariatin A
  2. Lasalocid A sodium salt
    CAS  25999-20-6
    CDX-L0015
    CDX-L0015-M05050 mg
    CHF 108.00
    CDX-L0015-M250250 mg
    CHF 326.00
    Lasalocid A sodium salt
  3. Lasalocid A Sodium Salt Solution
    CAS  25999-20-6
    CDX-L0515
    CDX-L0515-L0011 ml
    CHF 68.00
    CDX-L0515-LL252.5 ml
    CHF 122.00
    Lasalocid A Sodium Salt Solution
  4. Latanoprost
    CAS  130209-82-4
    CDX-L0069
    CDX-L0069-M01010 mg
    CHF 244.00
    CDX-L0069-M02525 mg
    CHF 489.00
    Latanoprost
  5. Leucettine L41
    CAS  1112978-84-3
    AG-MR-C0023
    AG-MR-C0023-M0011 mg
    CHF 70.00
    AG-MR-C0023-M0055 mg
    CHF 280.00
    AG-MR-C0023-M02525 mg
    CHF 980.00
    Leucettine L41
  6. Leucettinib-21
    CAS  2732859-75-3
    AG-MR-C0047
    AG-MR-C0047-M0011 mg
    CHF 100.00
    AG-MR-C0047-M0055 mg
    CHF 330.00
    AG-MR-C0047-M02525 mg
    CHF 980.00
    Leucettinib-21
  7. Leucettinib-92
    CAS  2732859-57-1
    AG-MR-C0049
    AG-MR-C0049-M0011 mg
    CHF 130.00
    AG-MR-C0049-M0055 mg
    CHF 430.00
    AG-MR-C0049-M02525 mg
    CHF 1'290.00
    Leucettinib-92
  8. Leupeptin . hemisulfate
    CAS  103476-89-7
    AG-CP3-7000
    AG-CP3-7000-M0055 mg
    CHF 45.00
    AG-CP3-7000-M02525 mg
    CHF 125.00
    AG-CP3-7000-M100100 mg
    CHF 370.00
    Leupeptin . hemisulfate
  9. Levocetirizine dihydrochloride
    CAS  130018-87-0
    CDX-L0121
    CDX-L0121-M01010 mg
    CHF 49.00
    CDX-L0121-M05050 mg
    CHF 189.00
    Levocetirizine dihydrochloride
  10. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed

Items 2121-2130 of 2823

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.